Receptors, Antigen, T-Cell
"Receptors, Antigen, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains.
Descriptor ID |
D011948
|
MeSH Number(s) |
D12.776.543.750.705.816.824
|
Concept/Terms |
Receptors, Antigen, T-Cell- Receptors, Antigen, T-Cell
- T-Cell Antigen Receptor
- Antigen Receptor, T-Cell
- Receptor, T-Cell Antigen
- T Cell Antigen Receptor
- T-Cell Receptors
- Receptors, T-Cell
- T Cell Receptors
- T-Cell Receptor
- Receptor, T-Cell
- T Cell Receptor
- Receptors, T-Cell Antigen
- Receptors, T Cell Antigen
- T-Cell Antigen Receptors
- Antigen Receptors, T-Cell
- Antigen Receptors, T Cell
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Antigen, T-Cell".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Antigen, T-Cell".
- Receptors, Antigen, T-Cell
- Complementarity Determining Regions
- Receptor-CD3 Complex, Antigen, T-Cell
- Receptors, Antigen, T-Cell, alpha-beta
- Receptors, Antigen, T-Cell, gamma-delta
This graph shows the total number of publications written about "Receptors, Antigen, T-Cell" by people in this website by year, and whether "Receptors, Antigen, T-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 5 | 2 | 7 |
1996 | 6 | 0 | 6 |
1997 | 0 | 2 | 2 |
1998 | 4 | 7 | 11 |
1999 | 3 | 2 | 5 |
2000 | 2 | 2 | 4 |
2001 | 1 | 5 | 6 |
2002 | 7 | 10 | 17 |
2003 | 2 | 6 | 8 |
2004 | 3 | 7 | 10 |
2005 | 7 | 8 | 15 |
2006 | 8 | 2 | 10 |
2007 | 4 | 6 | 10 |
2008 | 5 | 8 | 13 |
2009 | 8 | 6 | 14 |
2010 | 7 | 7 | 14 |
2011 | 8 | 6 | 14 |
2012 | 4 | 5 | 9 |
2013 | 7 | 11 | 18 |
2014 | 9 | 10 | 19 |
2015 | 7 | 11 | 18 |
2016 | 12 | 10 | 22 |
2017 | 20 | 9 | 29 |
2018 | 17 | 8 | 25 |
2019 | 11 | 14 | 25 |
2020 | 14 | 17 | 31 |
2021 | 17 | 14 | 31 |
2022 | 2 | 32 | 34 |
2023 | 4 | 29 | 33 |
2024 | 4 | 14 | 18 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Antigen, T-Cell" by people in Profiles.
-
Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel. Blood Adv. 2024 10 22; 8(20):5346-5354.
-
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs. Cancer Immunol Res. 2024 Oct 01; 12(10):1421-1437.
-
Germline mutations in a G protein identify signaling cross-talk in T cells. Science. 2024 Sep 20; 385(6715):eadd8947.
-
Effector memory-type regulatory T cells display phenotypic and functional instability. Sci Adv. 2024 Sep 06; 10(36):eadn3470.
-
Lipidomic scanning of self-lipids identifies headless antigens for natural killer T cells. Proc Natl Acad Sci U S A. 2024 Aug 20; 121(34):e2321686121.
-
First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors. J Immunother Cancer. 2024 Jul 22; 12(7).
-
A Unique Comprehensive Model to Screen Newborns for Severe Combined Immunodeficiency-An Ontario Single-Centre Experience Spanning 2013-2023. Genes (Basel). 2024 Jul 15; 15(7).
-
Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity. Cell Rep Med. 2024 Jul 16; 5(7):101628.
-
Hu8F4-CAR T cells with mutated Fc spacer segment improve target specificity and mediate anti-leukemia activity in vivo. Cytotherapy. 2024 Nov; 26(11):1331-1340.
-
CAR T-cell expansion: harmful or helpful? Blood Adv. 2024 06 25; 8(12):3311-3313.